Multidisciplinary Approach to High-Risk HR+/HER2- Breast Cancer Identification

Introduction

The June BC TALKS will feature five expert physicians: Prof. Michael Gnant (Austria), Prof. Marc Thill (Germany), Prof. Maria-João Cardoso (Portugal) and Prof. Giancarlo Pruneri (Italy).
This will be an expert MDT discussion on the identification of high-risk HR+/HER2- EBC and MBC and includes; Multidisciplinary In-Depth Insights, EBC Patient Case Study, MBC Patient Case Study, Panel Discussions and Live Q&A

Objectives

• Share data on the latest data for abemaciclib for patients with HR+ HER2-breast cancer in the EBC and MBC setting and discuss the impact of this data in clinical practice. It will be an expert MDT discussion on the identification of high-risk HR+/HER2- EBC and MBC and includes; Multidisciplinary In-Depth Insights, EBC Patient Case Study, MBC Patient Case Study, Panel Discussions and Live Q&A

This Course For :

Physician ( Oncology )
Resident / Fellow ( Oncology )

Speaker

Provided by :

Price

Course Fee

FREE

FREE
See Registration Policies, Cancellations & Refunds

Contact Information

Organization : Virtual Medical Academy
Phone : 920008161
Email : [email protected]

  • 11 Jun 2024    To    11 Jun 2024
  • 07:00 PM  To  08:00 PM
  • Certificate Available
  • Online Click Here
  • 34
  Add to Calendar 06/11/2024 07:00 PM 06/11/2024 08:00 PM Asia/ Riyadh Multidisciplinary Approach to High-Risk HR+/HER2- Breast Cancer Identification Multidisciplinary Approach to High-Risk HR+/HER2- Breast Cancer Identification https://medicalacademy.org/portal/event/view/2177
Multidisciplinary Approach to High-Risk HR+/HER2- Breast Cancer Identification